title: Severe cutaneous reaction to sorafenib: induction of tolerance.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Bauer
authors.forename: Bernhard
authors.initials: B
authors.lastname: Przybilla
authors.forename: Franziska
authors.initials: F
authors.lastname: Ruëff
mesh_terms: D000368:Aged; D001557:Benzenesulfonates / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004485:Eczema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D020714:Maximum Tolerated Dose; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib